Research progress of pyroptosis in leukemia

doi:10.3760/cma.j.cn371439-20230715-00131

Abstract

Abstract:

Pyroptosis is a programmed cell death mediated by the Gasdermin family of proteins，which is different from apoptosis and necrosis and accompanied by the release of a large number of pro-inflammatory factors. Leukemia is a malignant proliferative disease derived from hematopoietic stem cells，the pathogenesis and progression of which are related to many factors. In recent years，with the in-depth study on the mechanism of pyroptosis，it has been found that pyroptosis is closely related to the occurrence and development of leukemia. Further study of the mechanism of pyroptosis in leukemia can provide a new idea for the diagnosis and treatment of leukemia.

Key words: Pyroptosis, Leukemia, Neoplasms

Zhang Ting, Jia Xiuhong. Research progress of pyroptosis in leukemia[J]. Journal of International Oncology, 2023, 50(11): 696-700.

References 34

[1]	Long L, Assaraf YG, Lei ZN, et al. Genetic biomarkers of drug resistance: a compass of prognosis and targeted therapy in acute myeloid leukemia[J]. Drug Resist Updat, 2020, 52: 100703. DOI: 10.1016/j.drup.2020.100703.
[2]	Yu P, Zhang X, Liu N, et al. Pyroptosis: mechanisms and diseases[J]. Signal Transduct Target Ther, 2021, 6(1): 128. DOI: 10.1038/s41392-021-00507-5.
[3]	Zhao P, Wang M, Chen M, et al. Programming cell pyroptosis with biomimetic nanoparticles for solid tumor immunotherapy[J]. Biomaterials, 2020, 254: 120142. DOI: 10.1016/j.biomaterials.2020.120142.
[4]	Zychlinsky A, Prevost MC, Sansonetti PJ. Shigella flexneri induces apoptosis in infected macrophages[J]. Nature, 1992, 358(6382): 167-169. DOI: 10.1038/358167a0.
[5]	Wang H, Zhou X, Li C, et al. The emerging role of pyroptosis in pediatric cancers: from mechanism to therapy[J]. J Hematol Oncol, 2022, 15(1): 140. DOI: 10.1186/s13045-022-01365-6.
[6]	Shi J, Gao W, Shao F. Pyroptosis: gasdermin-mediated programmed necrotic cell death[J]. Trends Biochem Sci, 2017, 42(4): 245-254. DOI: 10.1016/j.tibs.2016.10.004. pmid: 27932073
[7]	Wang L, Hauenstein AV. The NLRP3 inflammasome: mechanism of action, role in disease and therapies[J]. Mol Aspects Med, 2020, 76: 100889. DOI: 10.1016/j.mam.2020.100889.
[8]	Wang K, Sun Q, Zhong X, et al. Structural mechanism for GSDMD targeting by autoprocessed caspases in pyroptosis[J]. Cell, 2020, 180(5): 941-955.e20. DOI: 10.1016/j.cell.2020.02.002. pmid: 32109412
[9]	Bauer R, Rauch I. The NAIP/NLRC4 inflammasome in infection and pathology[J]. Mol Aspects Med, 2020, 76: 100863. DOI: 10.1016/j.mam.2020.100863.
[10]	Wang Y, Gao W, Shi X, et al. Chemotherapy drugs induce pyroptosis through caspase-3 cleavage of a gasdermin[J]. Nature, 2017, 547(7661): 99-103. DOI: 10.1038/nature22393.
[11]	Rogers C, Erkes DA, Nardone A, et al. Gasdermin pores permeabilize mitochondria to augment caspase-3 activation during apoptosis and inflammasome activation[J]. Nat Commun, 2019, 10(1): 1689. DOI: 10.1038/s41467-019-09397-2. pmid: 30976076
[12]	杨羽依, 刘秀萍. Gasdermin E诱导细胞焦亡的研究进展[J]. 中华病理学杂志, 2021, 50(4): 421-424. DOI: 10.3760/cma.j.cn112151-20200724-00589.
[13]	Chen KW, Demarco B, Heilig R, et al. Extrinsic and intrinsic apoptosis activate pannexin-1 to drive NLRP3 inflammasome assembly[J]. EMBO J, 2019, 38(10): e101638. DOI: 10.15252/embj.2019101638.
[14]	Zhou T, Qian K, Li YY, et al. The pyroptosis-related gene signature predicts prognosis and reveals characterization of the tumor immune microenvironment in acute myeloid leukemia[J]. Front Pharmacol, 2022, 13: 951480. DOI: 10.3389/fphar.2022.951480.
[15]	Johnson DC, Taabazuing CY, Okondo MC, et al. DPP8/DPP9 inhibitor-induced pyroptosis for treatment of acute myeloid leukemia[J]. Nat Med, 2018, 24(8): 1151-1156. DOI: 10.1038/s41591-018-0082-y. pmid: 29967349
[16]	Ren J, Tao Y, Peng M, et al. Targeted activation of GPER enhances the efficacy of venetoclax by boosting leukemic pyroptosis and CD8⁺ T cell immune function in acute myeloid leukemia[J]. Cell Death Dis, 2022, 13(10): 915. DOI: 10.1038/s41419-022-05357-9.
[17]	Leu WJ, Chang HS, Chen IS, et al. Antileukemic natural product induced both apoptotic and pyroptotic programmed cell death and differentiation effect[J]. Int J Mol Sci, 2021, 22(20): 11239. DOI: 10.3390/ijms222011239.
[18]	Tian W, Wang Z, Tang NN, et al. Ascorbic acid sensitizes colorectal carcinoma to the cytotoxicity of arsenic trioxide via promoting reactive oxygen species-dependent apoptosis and pyroptosis[J]. Front Pharmacol, 2020, 11: 123. DOI: 10.3389/fphar.2020.00123. pmid: 32153415
[19]	Yang W, Liu S, Li Y, et al. Pyridoxine induces monocyte-macrophages death as specific treatment of acute myeloid leukemia[J]. Cancer Lett, 2020, 492: 96-105. DOI: 10.1016/j.canlet.2020.08.018. pmid: 32860849
[20]	Zhou L, Yao Q, Ma L, et al. TAF1 inhibitor Bay-299 induces cell death in acute myeloid leukemia[J]. Transl Cancer Res, 2021, 10(12): 5307-5318. DOI: 10.21037/tcr-21-2295. pmid: 35116379
[21]	Young MM, Bui V, Chen C, et al. FTY720 induces non-canonical phosphatidylserine externalization and cell death in acute myeloid leukemia[J]. Cell Death Dis, 2019, 10(11): 847. DOI: 10.1038/s41419-019-2080-5. pmid: 31699964
[22]	Zhou Y, Kong Y, Jiang M, et al. Curcumin activates NLRC4, AIM2, and IFI16 inflammasomes and induces pyroptosis by up-regulated ISG3 transcript factor in acute myeloid leukemia cell lines[J]. Cancer Biol Ther, 2022, 23(1): 328-335. DOI: 10.1080/15384047.2022.2058862. pmid: 35435150
[23]	Wiemels JL, Walsh KM, de Smith AJ, et al. GWAS in childhood acute lymphoblastic leukemia reveals novel genetic associations at chromosomes 17q12 and 8q24.21[J]. Nat Commun, 2018, 9(1): 286. DOI: 10.1038/s41467-017-02596-9. pmid: 29348612
[24]	Dai Y, Huang J, Kuang P, et al. Dasatinib and interferon alpha synergistically induce pyroptosis-like cell death in philadelphia chromosome positive acute lymphoblastic leukemia[J]. Am J Cancer Res, 2022, 12(6): 2817-2832. pmid: 35812060
[25]	Mondet J, Chevalier S, Mossuz P. Pathogenic roles of S100A8 and S100A9 proteins in acute myeloid and lymphoid leukemia: clinical and therapeutic impacts[J]. Molecules, 2021, 26(5): 1323. DOI: 10.3390/molecules26051323.
[26]	Wang Z, Wu Z, Liu Y, et al. New development in CAR-T cell therapy[J]. J Hematol Oncol, 2017, 10(1): 53. DOI: 10.1186/s13045-017-0423-1.
[27]	Liu Y, Fang Y, Chen X, et al. Gasdermin E-mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome[J]. Sci Immunol, 2020, 5(43): eaax7969. DOI: 10.1126/sciimmunol.aax7969.
[28]	Minciacchi VR, Kumar R, Krause DS. Chronic myeloid leukemia: a model disease of the past, present and future[J]. Cells, 2021, 10(1): 117. DOI: 10.3390/cells10010117.
[29]	Zhang A, Yu J, Yan S, et al. The genetic polymorphism and expression profiles of NLRP3 inflammasome in patients with chronic myeloid leukemia[J]. Hum Immunol, 2018, 79(1): 57-62. DOI: 10.1016/j.humimm.2017.10.013. pmid: 29097263
[30]	Dong HQ, Liang SJ, Xu YL, et al. Liproxstatin-1 induces cell cycle arrest, apoptosis, and caspase-3/GSDME-dependent secon-dary pyroptosis in K562 cells[J]. Int J Oncol, 2022, 61(4): 119. DOI: 10.3892/ijo.2022.5409.
[31]	Zhang J, Chen Y, He Q. Distinct characteristics of dasatinib-induced pyroptosis in gasdermin E-expressing human lung cancer A549 cells and neuroblastoma SH-SY5Y cells[J]. Oncol Lett, 2020, 20(1): 145-154. DOI: 10.3892/ol.2020.11556. pmid: 32565942
[32]	Sadaf S, Awasthi D, Singh AK, et al. Pyroptotic and apoptotic cell death in iNOS and nNOS overexpressing K562 cells: a mechanistic insight[J]. Biochem Pharmacol, 2020, 176: 113779. DOI: 10.1016/j.bcp.2019.113779.
[33]	陈丽丽, 廖芬芳, 陈向洁, 等. 鬼臼苦素诱导Ph⁺慢性髓系白血病细胞焦亡及其相关分子机制研究[J]. 广东药科大学学报, 2022, 38(3): 1-5. DOI: 10.16809/j.cnki.2096-3653.2022031402.
[34]	Sha Y, Jiang R, Miao Y, et al. The pyroptosis-related gene signature predicts prognosis and indicates the immune microenvironment status of chronic lymphocytic leukemia[J]. Front Immunol, 2022, 13: 939978. DOI: 10.3389/fimmu.2022.939978.